利尿剂在心力衰竭中作用的重新评估。
Reappraisal of the role of diuretics in heart failure.
作者信息
Guglin Maya
机构信息
University of South Florida, Tampa, USA.
出版信息
Cardiol Rev. 2009 Mar-Apr;17(2):56-9. doi: 10.1097/CRD.0b013e31818eba68.
PMID:19367146
Abstract
The focus of this review is to explore the controversy between the broad acceptance of loop diuretics as a first-line treatment for heart failure (HF) and the data regarding their association to increased morbidity and mortality in HF. We conclude that existing evidence is sufficient to recognize that diuretics are essential for the management of HF. Selection bias is the likely source of their connection to poor outcomes.
摘要
本综述的重点是探讨袢利尿剂被广泛接受作为心力衰竭（HF）一线治疗方法与有关其与HF发病率和死亡率增加相关的数据之间的争议。我们得出结论，现有证据足以认识到利尿剂对HF的管理至关重要。选择偏倚可能是它们与不良结局相关的原因。
相似文献
1
Reappraisal of the role of diuretics in heart failure.利尿剂在心力衰竭中作用的重新评估。
Cardiol Rev. 2009 Mar-Apr;17(2):56-9. doi: 10.1097/CRD.0b013e31818eba68.
2
Diuretic management in heart failure.心力衰竭中的利尿剂管理
Congest Heart Fail. 2010 Jul;16 Suppl 1:S68-72. doi: 10.1111/j.1751-7133.2010.00172.x.
3
Contemporary issues in the pharmacologic management of acute heart failure.急性心力衰竭药物治疗的当代问题
Crit Care Clin. 2006 Apr;22(2):199-219, v. doi: 10.1016/j.ccc.2006.02.008.
4
[Diuretic therapy in heart failure].[心力衰竭的利尿治疗]
Med Clin (Barc). 2014 Feb 20;142(4):163-70. doi: 10.1016/j.medcli.2013.04.027. Epub 2013 Jun 12.
5
Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?循证时代急性失代偿性心力衰竭的管理：当前护理标准背后的证据是什么？
Heart Lung. 2008 May-Jun;37(3):173-8. doi: 10.1016/j.hrtlng.2007.05.001.
6
Treatment of acute decompensated heart failure: harmful effects of high doses of loop diuretics?急性失代偿性心力衰竭的治疗：高剂量袢利尿剂的有害影响？
Cardiology. 2009;113(1):9-11. doi: 10.1159/000164148. Epub 2008 Oct 17.
7
Loop diuretics in patients with heart failure: time to change to torsemide?心力衰竭患者使用袢利尿剂：是时候改用托拉塞米了吗？
J Cardiovasc Pharmacol. 2009 Jun;53(6):435-7. doi: 10.1097/FJC.0b013e3181a71a78.
8
Impact of worsening renal function related to medication in heart failure.与心力衰竭相关的药物导致肾功能恶化的影响。
Eur J Heart Fail. 2015 Feb;17(2):159-68. doi: 10.1002/ejhf.210. Epub 2014 Dec 30.
9
Diuretic therapy in heart failure: current controversies and new approaches for fluid removal.心力衰竭中的利尿剂治疗：当前的争议和新的液体清除方法。
J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):563-70. doi: 10.2459/JCM.0b013e3283376bfa.
10
Acute decompensated heart failure.急性失代偿性心力衰竭
CMAJ. 2007 Jul 17;177(2):175; author reply 175-6. doi: 10.1503/cmaj.1070054.
引用本文的文献
1
Chronic Heart Failure Clinical Practice Guidelines' Class 1-A Pharmacologic Recommendations: Start-to-End Synergistic Drug Therapy?《慢性心力衰竭临床实践指南》1-A类药物治疗建议：全程协同药物治疗？
ASEAN Heart J. 2016 Mar 8;24(1):4. doi: 10.7603/s40602-016-0004-5. eCollection 2016 Mar.
2
Congestion is the driving force behind heart failure.充血是心力衰竭背后的驱动力。
Curr Heart Fail Rep. 2012 Sep;9(3):219-27. doi: 10.1007/s11897-012-0093-9.
3
Key role of congestion in natural history of heart failure.充血在心力衰竭自然病程中的关键作用。
Int J Gen Med. 2011;4:585-91. doi: 10.2147/IJGM.S24108. Epub 2011 Aug 15.
4
Diuretics as pathogenetic treatment for heart failure.利尿剂治疗心力衰竭的病理生理学机制。
Int J Gen Med. 2011 Jan 23;4:91-8. doi: 10.2147/IJGM.S16635.
Zotero 插件